Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2baf849d216e689ecc40ccc931a7a7bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_119d03d40f99e0ca07888583f0f483c0 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10 |
filingDate |
1999-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8cdb74a9d167930b52d94fbef21f49f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7169b07ff3d76f52e0193f4724da9eaf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7ae6024a6800c9a713f747f69258255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eac0f50ef0bcd1e60208162b02dbe509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b1222b1a44ed8e8f3fad05b94475cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_858c82b7aded42a0b49ec1185299aa51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4e0fdde95044f5a13fffc6483eac6c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6724edb82504facf10607df9d9be69b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67541ba3bb4a352e7439048afaa2f2e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a4a1ef24edb907a9c59ee9a86b63a37 |
publicationDate |
2001-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
SK-7062001-A3 |
titleOfInvention |
Remedial agent for erectile dysfunction |
abstract |
The present invention provides a remedial agent for erectile dysfunction which comprises a 3(2H)-pyridazinone derivative represented by the formula (I): <CHEM> wherein each symbol is the same as defined in the specification or a pharmaceutically acceptable salt thereof as an active ingredient. |
priorityDate |
1998-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |